Why the study?
Takotsubo syndrome (TTS) can trigger cardiopulmonary arrest (CPA) or develop secondary to CPA, yet both scenarios are often treated as a single entity. It remained unclear whether TTS-induced CPA and post-CPA TTS represent distinct clinical phenotypes with different prognostic implications.
Does TTS-induced cardiopulmonary arrest confer worse in-hospital and long-term survival compared to post-cardiopulmonary arrest TTS in patients with Takotsubo syndrome and cardiopulmonary arrest?
Cohort (n=38)
Does TTS-induced cardiopulmonary arrest confer worse in-hospital and long-term survival compared to post-cardiopulmonary arrest TTS in patients with Takotsubo syndrome and cardiopulmonary arrest?
Patients with Takotsubo syndrome who experience cardiopulmonary arrest as a direct consequence of the cardiomyopathy have a 100% rate of recurrent ventricular arrhythmias and substantially higher in-hospital and long-term mortality than those who develop Takotsubo syndrome secondary to arrest from other causes.
TTS-induced CPA may mark a higher-risk phenotype needing vigilance; leaves open whether prospective studies confirm distinct entities or guide therapy.
Background Cardiopulmonary arrest (CPA) is a life-threatening complication of Takotsubo syndrome (TTS). Conversely, TTS may also develop secondary to the physiological stress of CPA or its resuscitation. Despite potentially distinct underlying mechanisms, these scenarios are often considered a single clinical entity. Whether TTS triggering CPA and TTS occurring after CPA represent distinct clinical phen9otypes with different prognostic implications remains unclear. Purpose To determine whether TTS-associated CPA comprises distinct clinical phenotypes and to evaluate differences in clinical characteristics, in-hospital events, and long-term mortality. Methods In this retrospective registry of 447 consecutive patients with TTS, we identified 38 patients who experienced CPA immediately prior to TTS diagnosis. CPA included ventricular tachycardia/fibrillation (VT/VF), pulseless electrical activity, or asystole. Patients were categorized into two groups: (1) TTS-induced CPA, defined as CPA without an alternative identifiable cause, suggesting TTS as the precipitating event (n=16); and (2) post-CPA TTS, defined as TTS occurring after CPA due to a separate identifiable condition (e.g., sepsis or subarachnoid hemorrhage) (n=22). Baseline characteristics and in-hospital cardiovascular events (including cardiogenic shock and recurrent VT/VF) were compared between groups. Long-term survival was assessed using Kaplan–Meier analysis and Cox proportional hazards models to estimate hazard ratios (HRs) with 95% confidence intervals (CIs). Results There were no significant differences in age (65.8±9.2 vs. 60.0±18.0 years, p=0.81) or sex distribution (56.2% vs. 77.3% female, p=0.29) between the groups. In-hospital cardiogenic shock occurred with similar frequency (43.8% vs. 54.5%, p=0.74). However, all-cause in-hospital mortality was significantly higher in the TTS-induced CPA group (43.8% vs. 9.1%, p=0.02). Recurrent VT/VF after TTS diagnosis occurred in 100% of the TTS-induced CPA group compared with 13.6% in the post-CPA TTS group (p<0.01). During follow-up, the TTS-induced CPA phenotype was associated with significantly worse long-term survival (HR 0.30, 95% CI 0.31–0.90, p=0.022). Conclusions TTS-associated CPA comprises two clinically distinct phenotypes with markedly different arrhythmic burden and mortality risk. TTS-induced CPA is associated with substantially worse short- and long-term outcomes, underscoring the need for intensified monitoring and risk stratification in this high-risk subgroup.
No takes yet. Share an insight, caveat, or question.
Miyakoda et al. (2026) conducted a cohort in Takotsubo syndrome with cardiopulmonary arrest (n=38). TTS-induced cardiopulmonary arrest vs. Post-cardiopulmonary arrest TTS was evaluated on All-cause in-hospital mortality and long-term survival (HR 0.30, 95% CI 0.31-0.90, p=0.022).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: